Trial intelligence / Profile preview

Phase 0 crossover pharmacokinetic study of controlled-release capecitabine ModraCape001 versus Xeloda

NL-OMON37961Active, not recruiting

Sponsor

Netherlands Cancer Institute

Start

Dec 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1